Skip to main content
. 2018 Jan 13;144(3):519–529. doi: 10.1007/s00432-018-2580-1

Fig. 1.

Fig. 1

The immunostaining of the analyzed markers in MPNST samples. a Low expression of survivin (×200). b The p53 strong immunoreactivity (×400). c High cyclin D nuclear staining (strong immunoreactivity in more than 50% of cells). d High diffuse nuclear and cytoplasmatic immunoreactivity of osteopontin (×200). e Fibronectin high expression in more than 90% cells (×200)